Covert operations of uropathogenic Escherichia coli within the Urinary Tract

Traffic

Volumn 6, Issue 1, 2005, Pages 18-31

  Bower, Jean M ^a   Eto, Danelle S ^a   Mulvey, Matthew A ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Adhesion; Bladder; Cystitis; Fimbriae; Invasion; Lipid rafts; Pili; Uroplakin

Indexed keywords

ADHESIN; BACTERIAL PROTEIN; VIRULENCE FACTOR;

BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; BACTERIUM PILUS; CELL INVASION; CELL MEMBRANE PERMEABILITY; ESCHERICHIA COLI; HOST CELL; HUMAN; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RECURRENT INFECTION; REVIEW; URINARY TRACT INFECTION;

ADHESINS, ESCHERICHIA COLI; ANIMALS; BACTERIAL ADHESION; BACTERIAL TOXINS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; FIMBRIAE, BACTERIAL; HUMANS; KIDNEY; MODELS, BIOLOGICAL; URINARY BLADDER; URINARY TRACT; URINARY TRACT INFECTIONS; VIRULENCE;

EID: 12444281840     PISSN: 13989219     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0854.2004.00251.x     Document Type: Review

References (117)

1. Janeway CA, Travers P, Walport M, Capra JD. Immunobiology. The Immune System in Health and Disease, 4th edn. New York: Garland, 1999.
2. LaPenta D, Rubens C, Chi E, Cleary PP. Group A streptococci efficiently invade human respiratory epithelial cells. Proc Natl Acad Sci U S A 1994;91:12115-12119.
3. Osterlund A, Engstrand L. Intracellular penetration and survival of Streptococcus pyogenes in respiratory epithelial cells in vitro. Acta Otolaryngol 1995;115:685-688.
4. Burns JL, Jonas M, Chi EY, Clark DK, Berger A, Griffith A. Invasion of respiratory epithelial cells by Burkholderia (Pseudomonas) cepacia. Infect Immun 1996;64:4054-4059.
5. Petersen AM, Krogfelt KA. Helicobacter pylori: an invading microorganism? A review. FEMS Immunol Med Microbiol 2003;36:117-126.
6. St Geme JW 3rd. Molecular and cellular determinants of non-typeable Haemophilus influenzae adherence and invasion. Cell Microbiol 2002; 4:191-200.
7. Mulvey MA, Lopez-Boado YS, Wilson CL, Roth R, Parks WC, Hauser J, Hultgren SJ. Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli. Science 1998;282:1494-1497.
8. Osterlund A, Popa R, Nikkila T, Scheynius A, Engstrand L. Intracellular reservoir of Streptococcus pyogenes in vivo: a possible explanation for recurrent pharyngotonsillitis. Laryngoscope 1997;107:640-647.
9. Podbielski A, Beckert S, Schattke R, Leithauser F, Lestin F, Gossler B, Kreikemeyer B Epidemiology and virulence gene expression of intracellular group A streptococci in tonsils of recurrently infected adults. Int J Med Microbiol 2003;293:179-190.
10. Murphy TF. Bacterial otitis media: pathogenetic considerations. Pediatr Infect Dis J 2000;19:S9-S15;discussion S15-16.
11. Mulvey MA, Schilling JD, Hultgren SJ. Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection. Infect Immun 2001;69:4572-4579.
12. Schilling JD, Lorenz RG, Hultgren SJ. Effect of trimethoprimsulfamethoxazole on recurrent bacteriuria and bacterial persistence in mice infected with uropathogenic Escherichia coli. Infect Immun 2002;70:7042-7049.
13. Foxman B, Barlow R, D'Arcy H, Gillespie B, Sobel JD. Urinary tract infection: self-reported incidence and associated costs. Ann Epidemiol 2000;10:509-515.
14. Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med 2002;113(Suppl. 1A):5S-13S.
15. McBean M, Rajamani S. Increasing rates of hospitalization due to septicemia in the US elderly population, 1986-97. J Infect Dis 2001;183:596-603.
16. Siegman-Igra Y, Fourer B, Orni-Wasserlauf R, Golan Y, Noy A, Schwartz D, Giladi M. Reappraisal of community-acquired bacteremia: a proposal of a new classification for the spectrum of acquisition of bacteremia. Clin Infect Dis 2002;34:1431-1439.
17. Kantor AF, Hartge P, Hoover RN, Narayana AS, Sullivan JW, Fraumeni JF Jr. Urinary tract infection and risk of bladder cancer. Am J Epidemiol 1984;119:510-515.
18. La Vecchia C, Negri E, D'Avanzo B, Savoldelli R, Franceschi S. Genital and urinary tract diseases and bladder cancer. Cancer Res 1991;51: 629-631.
19. Yamamoto M, Wu HH, Momose H, Rademaker A, Oyasu R. Marked enhancement of rat urinary bladder carcinogenesis by heat-killed Escherichia coli. Cancer Res 1992;52:5329-5333.
20. Welch RA, Burland V, Plunkett G 3rd, Redford P, Roesch P, Rasko D, Buckles EL, Liou SR, Boutin A, Hackett J, Stroud D, Mayhew GF, Rose DJ, Zhou S, Schwartz DC, at al. Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli. Proc Natl Acad Sci U S A 2002;99:17020-17024.
21. Miyazaki J, Ba-Thein W, Kumao T, Akaza H, Hayashi H. Identification of a type III secretion system in uropathogenic Escherichia coli. FEMS Microbiol Lett 2002;212:221-228.
22. Srinivasan U, Foxman B, Marrs CF. Identification of a gene encoding heat-resistant agglutinin in Escherichia coli as a putative virulence factor in urinary tract infection. J Clin Microbiol 2003;41:285-289.
23. Condron C, Toomey D, Casey RG, Shaffii M, Creagh T, Bouchier-Hayes D. Neutrophil bactericidal function is defective in patients with recurrent urinary tract infections. Urol Res 2003;31:329-334.
24. Brauner A, Jacobson SH, Kuhn I. Urinary Escherichia coli causing recurrent infections - a prospective follow-up of biochemical phenotypes. Clin Nephrol 1992;38:318-323.
25. Ikaheimo R, Siitonen A, Heiskanen T, Karkkainen U, Kuosmanen P, Lipponen P, Makela PH. Recurrence of urinary tract infection in a primary care setting: analysis of a 1-year follow-up of 179 women. Clin Infect Dis 1996;22:91-99.
26. Karkkainen UM, Ikaheimo R, Katila ML, Siitonen A. Recurrence of urinary tract infections in adult patients with community-acquired pyelonephritis caused by E. coli: a 1-year follow-up. Scand J Infect Dis 2000;32:495-499.
27. Russo TA, Stapleton A, Wenderoth S, Hooton TM, Stamm WE. Chromosomal restriction fragment length polymorphism analysis of Escherichia coli strains causing recurrent urinary tract infections in young women. J Infect Dis 1995;172:440-445.
28. Jacobson SH, Kuhn I, Brauner A. Biochemical fingerprinting of urinary Escherichia coli causing recurrent infections in women with pyelonephritic renal scarring. Scand J Urol Nephrol 1992;26:373-377.
29. Mulvey MA, Schilling JD, Martinez JJ, Hultgren SJ. Bad bugs and beleaguered bladders: interplay between uropathogenic Escherichia coli and innate host defenses. Proc Natl Acad Sci U S A 2000;97: 8829-8835.
30. Justice SS, Hung C, Theriot JA, Fletcher DA, Anderson GG, Footer MJ, Hultgren SJ. Differentiation and developmental pathways of uropathogenic Escherichia coli in urinary tract pathogenesis. Proc Natl Acad Sci U S A 2004;101:1333-1338.
31. Caprioli A, Falbo V, Rode LG, Ruggeri FM, Zona C. Partial purification and characterization of an Escherichia coli toxic factor that induces morphological cell alterations. Infect Immun 1983;39:1300-1306.
32. Schmidt G, Sehr P, Wilm M, Selzer J, Mann M, Aktories K. Gln 63 of Rho is deamidated by Escherichia coli cytotoxic necrotizing factor-1. Nature 1997;387:725-729.
33. Flatau G, Lemichez E, Gauthier M, Chardin P, Paris S, Fiorentini C, Boquet P. Toxin-induced activation of the G protein p21 Rho by deamidation of glutamine. Nature 1997;387:729-733.
34. Lerm M, Selzer J, Hoffmeyer A, Rapp UR, Aktories K, Schmidt G. Deamidation of Cdc42 and Rac by Escherichia coli cytotoxic necrotizing factor 1: activation of c-Jun N-terminal kinase in HeLa cells. Infect Immun 1999;67:496-503.
35. Mills M, Meysick KC, O'Brien AD. Cytotoxic necrotizing factor type 1 of uropathogenic Escherichia coli kills cultured human uroepithelial 5637 cells by an apoptotic mechanism. Infect Immun 2000;68: 5869-5880.
36. Chung JW, Hong SJ, Kim KJ, Goti D, Stins MF, Shin S, Dawson VL, Dawson TM, Kim KS. 37-kDa laminin receptor precursor modulates cytotoxic necrotizing factor 1-mediated RhoA activation and bacterial uptake. J Biol Chem 2003;278:16857-16862.
37. Rippere-Lampe KE, O'Brien AD, Conran R, Lockman HA. Mutation of the gene encoding cytotoxic necrotizing factor type 1 cnf (1) attenuates the virulence of uropathogenic Escherichia coli. Infect Immun 2001;69: 3954-3964.
38. Johnson DE, Drachenberg C, Lockatell CV, Island MD, Warren JW, Donnenberg MS. The role of cytotoxic necrotizing factor-1 in colonization and tissue injury in a murine model of urinary tract infection. FEMS Immunol Med Microbiol 2000;28:37-41.
39. Fournout S, Dozois CM, Odin M, Desautels C, Peres S, Herault F, Daigle F, Segafredo C, Laffitte J, Oswald E, Fairbrother JM, Oswald IP. Lack of a role of cytotoxic necrotizing factor 1 toxin from Escherichia coli in bacterial pathogenicity and host cytokine response in infected germfree piglets. Infect Immun 2000;68:839-847.
40. Khan NA, Wang Y, Kim KJ, Chung JW, Wass CA, Kim KS. Cytotoxic necrotizing factor-1 contributes to Escherichia coli K1 invasion of the central nervous system. J Biol Chem 2002;277:15607-15612.
41. Johnson JR, Delavari P, O'Bryan TT. Escherichia coli O18: K1.H7 isolates from patients with acute cystitis and neonatal meningitis exhibit common phylogenetic origins and virulence factor profiles. J Infect Dis 2001;183:425-434.
42. Doye A, Mettouchi A, Bossis G, Clement R, Buisson-Touati C, Flatau G, Gagnoux L, Piechaczyk M, Boquet P, Lemichez E. CNF1 exploits the ubiquitin-proteasome machinery to restrict Rho GTPase activation for bacterial host cell invasion. Cell 2002; 111:553-564.
43. Lerm M, Pop M, Fritz G, Aktories K, Schmidt G. Proteasomal degradation of cytotoxic necrotizing factor 1-activated rac. Infect Immun 2002; 70:4053-4058.
44. Mulvey MA, Hultgren SJ. Adhesion, Bacterial. In: Encyclopedia of Microbiology. London: Academic Press, 2000: 42-52.
45. Nowicki B, Selvarangan R, Nowicki S. Family of Escherichia coli Dr adhesins: decay-accelerating factor receptor recognition and invasiveness. J Infect Dis 2001;183(Suppl. 1):S24-S27.
46. Anderson KL, Billington J, Pettigrew D, Cota E, Simpson P, Roversi P, Chen HA, Urvil P, du Merle L, Barlow PN, Medof ME, Smith RA, Nowicki B, Le Bouguenec C, Lea SM, et al. An atomic resolution model for assembly, architecture, and function of the Dr adhesins. Mol Cell 2004;15:647-657.
47. Berger CN, Billker O, Meyer TF, Servin AL, Kansau I. Differential recognition of members of the carcinoembryonic antigen family by Afa/Dr adhesins of diffusely adhering Escherichia coli (Afa/Dr DAEC). Mol Microbiol 2004;52:963-983.
48. Plancon L, Du Merle L, Le Friec S, Gounon P, Jouve M, Guignot J, Servin A, Le Bouguenec C. Recognition of the cellular beta1-chain integrin by the bacterial AfaD invasin is implicated in the internalization of afa-expressing pathogenic Escherichia coli strains. Cell Microbiol 2003;5:681-693.
49. Guignot J, Bernet-Camard MF, Pous C, Plancon L, Le Bouguenec C, Servin AL. Polarized entry of uropathogenic Afa/Dr diffusely adhering Escherichia coli strain IH11128 into human epithelial cells: evidence for α5β1 integrin recognition and subsequent internalization through a pathway involving caveolae and dynamic unstable microtubules. Infect Immun 2001;69:1856-1868.
50. Westerlund B, Kuusela P, Risteli J, Risteli L, Vartio T, Rauvala H, Virkola R, Korhonen TK. The O75X adhesin of uropathogenic Escherichia coli is a type IV collagen-binding protein. Mol Microbiol 1989;3:329-337.
51. Selvarangan R, Goluszko P, Singhal J, Carnoy C, Moseley S, Hudson B, Nowicki S, Nowicki B. Interaction of Dr achesin with collagen type IV is a critical step in Escherichia coli renal persistence. Infect Immun 2004;72:4827-4835.
52. Goluszko P, Niesel D, Nowicki B, Selvarangan R, Nowicki S, Hart A, Pawelczyk E, Das M, Urvil P, Hasan R. Dr operon-associated invasiveness of Escherichia coli from pregnant patients with pyelonephritis. Infect Immun 2001;69:4678-4680.
53. Hart A, Nowicki BJ, Reisner B, Pawelczyk E, Goluszko P, Urvil P, Anderson G, Nowicki S. Ampicillin-resistant Escherichia coli in gestational pyelonephritis: increased occurrence and association with the colonization factor Dr adhesin. J Infect Dis 2001;183: 1526-1529.
54. Selvarangan R, Goluszko P, Popov V, Singhal J, Pham T, Lublin DM, Nowicki S, Nowicki B. Role of decay-accelerating factor domains and anchorage in internalization of Dr-fimbriated Escherichia coli. Infect Immun 2000;68:1391-1399.
55. Fang L, Nowicki BJ, Urvil P, Goluszko P, Nowicki S, Young SL, Yallampalli C. Epithelial invasion by Escherichia coli bearing Dr fimbriae is controlled by nitric oxide-regulated expression of CD55. Infect Immun 2004;72:2907-2914.
56. Lundberg JO, Ehren I, Jansson O, Adolfsson J, Lundberg JM, Weitzberg E, Alving K, Wiklund NP. Elevated nitric oxide in the urinary bladder in infectious and noninfectious cystitis. Urology 1996;48: 700-702.
57. Poljakovic M, Svensson ML, Svanborg C, Johansson K, Larsson B, Persson K. Escherichia coli induced inducible nitric oxide synthase and cyclooxygenase expression in the mouse bladder and kidney. Kidney Int 2001;59:893-904.
58. Tieng V, Le Bouguenec C, du Merle L, Bertheau P, Desreumaux P, Janin A, Charron D, Toubert A. Binding of Escherichia coli adhesin AfaE to CD55 triggers cell-surface expression of the MHC class I-related molecule MICA. Proc Natl Acad Sci U S A 2002;99:2977-2982.
59. Betis F, Brest P, Hofman V, Guignot J, Bernet-Camard MF, Rossi B, Servin A, Hofman P. The Afa/Dr achesins of diffusely adhering Escherichia coli stimulate interleukin-8 secretion, activate mitogen-activated protein kinases, and promote polymorphonuclear transepithelial migration in T84 polarized epithelial cells. Infect Immun 2003; 71:1068-1074.
60. + T lymphocytes. Nat Immunol 2002;3:229-236.
61. Jouve M, Garcia MI, Courcoux P, Labigne A, Gounon P, Le Bouguenec C. Adhesion to and invasion of HeLa cells by pathogenic Eschenchia coli carrying the afa-3 gene cluster are mediated by the AfaE and AfaD proteins, respectively. Infect Immun 1997;65:4082-4089.
62. Goluszko P, Popov V, Selvarangan R, Nowicki S, Pham T, Nowicki BJ. Dr fimbriae operon of uropathogenic Escherichia coli mediate microtubule-dependent invasion to the HeLa epithelial cell line. J Infect Dis 1997;176:158-167.
63. Kansau I, Berger C, Hospital M, Amsellem R, Nicolas V, Servin AL, Bernet-Camard MF. Zipper-like internalization of Dr-positive Escherichia coli by epithelial cells is preceded by an adhesin-induced mobilization of raft-associated molecules in the initial step of adhesion. Infect Immun 2004;72:3733-3742.
64. McCaw SE, Liao EH, Gray-Owen SD. Engulfment of Neisseria gonorrhoeae: revealing distinct processes of bacterial entry by individual carcinoembryonic antigen-related cellular adhesion molecule family receptors. Infect Immun 2004;72:2742-2752.
65. Clausen JD, Christiansen G, Holst HU, Birkelund S. Chlamydia trachomatis utilizes the host cell microtubule network during early events of infection. Mol Microbiol 1997;25:441-449.
66. Oelschlaeger TA, Guerry P, Kopecko DJ. Unusual microtubule-dependent endocytosis mechanisms triggered by Campylobacter jejuni and Citrobacter freundii. Proc Natl Acad Sci U S A 1993;90:6884-6888.
67. Young VB, Falkow S, Schoolnik GK. The invasin protein of Yersinia enterocolitica: internalization of invasin-bearing bacteria by eukaryotic cells is associated with reorganization of the cytoskeleton. J Cell Biol 1992;116:197-207.
68. Brinton CC. Non-flagellar appendages of bacteria. Nature 1959;183: 782-786.
69. Buchanan K, Falkow S, Hull RA, Hull SI. Frequency among Enterobacteriaceae of the DNA sequences encoding type 1 pili. J Bacteriol 1985;162:799-803.
70. Russell PW, Orndorff PE. Lesions in two Escherichia coli type 1 pilus genes alter pilus number and length without affecting receptor binding. J Bacteriol 1992;174:5923-5935.
71. Jones CH, Pinkner JS, Roth R, Hauser J, Nicholes AV, Abraham SN, Hultgren SJ. FimH adhesin of type 1 pili is assembled into a fibrillar tip structure in the Enterobacteriaceae. Proc Natl Acad Sci U S A 1995;92: 2081-2085.
72. Choudhury D, Thompson A, Stojanoff V, Langermann S, Pinkner J, Hultgren SJ, Knight SD. X-ray structure of the FimC-FimH chaperone-adhesin complex from uropathogenic Escherichia coli. Science 1999; 285:1061-1066.
73. Sokurenko EV, Courtney HS, Maslow J, Siitonen A, Hasty DL. Quantitative differences in adhesiveness of type 1 fimbriated Escherichia coli due to structural differences in fimH genes. J Bacteriol 1995;177: 3680-3686.
74. Sokurenko EV, Chesnokova V, Dykhuizen DE, Ofek I, Wu XR, Krogfelt KA, Struve C, Schembri MA, Hasty DL. Pathogenic adaptation of Escherichia coli by natural variation of the FimH achesin. Proc Natl Acad Sci U S A 1998;95:8922-8926.
75. Connell H, Agace W, Klemm P, Schembri M, Marild S, Svanborg C. Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary tract. Proc Natl Acad Sci USA 1996;93:9827-9832.
76. Langermann S, Palaszynski S, Barnhart M, Auguste G, Pinkner JS, Burlein J, Barren P, Koenig S, Leath S, Jones CH, Hultgren SJ. Prevention of mucosal Escherichia coli infection by FimH-adhesin-based systemic vaccination. Science 1997;276:607-611.
77. Mysorekar IU, Mulvey MA, Hultgren SJ, Gordon JI. Molecular regulation of urothelial renewal and host defenses during infection with uropathogenic Escherichia coli. J Biol Chem 2002;277:7412-7419.
78. Bahrani-Mougeot FK, Buckles EL, Lockatell CV, Hebel JR, Johnson DE, Tang CM, Donnenberg MS. Type 1 fimbriae and extracellular polysaccharides are preeminent uropathogenic Escherichia coli virulence determinants in the murine urinary tract. Mol Microbiol 2002;45: 1079-1093.
79. Zhou G, Mo WJ, Sebbel P, Min G, Neubert TA, Glockshuber R, Wu XR, Sun TT, Kong XP. Uroplakin Ia is the urothelial receptor for uropathogenic Escherichia coli: evidence from in vitro FimH binding. J Cell Sci 2001;114:4095-4103.
80. Apodaca G. The uroepithelium: not just a passive barrier. Traffic 2004;5:117-128.
81. Pouttu R, Puustinen T, Virkola R, Hacker J, Klemm P, Korhonen TK. Amino acid residue Ala-62 in the FimH fimbrial achesin is critical for the adhesiveness of meningitis-associated Escherichia coli to collagens. Mol Microbiol 1999;31:1747-1757.
82. Kukkonen M, Raunio T, Virkola R, Lahteenmaki K, Makela PH, Klemm P, Clegg S, Korhonen TK. Basement membrane carbohydrate as a target for bacterial adhesion: binding of type I fimbriae of Salmonella enterica and Escherichia coli to laminin. Mol Microbiol 1993;7:229-237.
83. Pak J, Pu Y, Zhang ZT, Hasty DL, Wu XR. Tamm-Horsfall protein binds to type 1 fimbriated Escherichia coli and prevents E. coli from binding to uroplakin Ia and Ib receptors. J Biol Chem 2001;276: 9924-9930.
84. Sauter SL, Rutherfurd SM, Wagener C, Shively JE, Hefta SA. Identification of the specific oligosaccharide sites recognized by type 1 fimbriae from Escherichia coli on nonspecific cross-reacting antigen, a CD66 cluster granulocyte glycoprotein. J Biol Chem 1993;268: 15510-15516.
85. Sokurenko EV, Courtney HS, Abraham SN, Klemm P, Hasty DL. Functional heterogeneity of type 1 fimbriae of Escherichia coli. Infect Immun 1992;60:4709-4719.
86. Bates JM, Raffi HM, Prasadan K, Mascarenhas R, Laszik Z, Maeda N, Hultgren SJ, Kumar S.Tamm-Horsfall protein knockout mice are more prone to urinary tract infection: rapid communication. Kidney Int 2004;65:791-797.
87. Mo L, Zhu XH, Huang HY, Shapiro E, Hasty DL, Wu XR. Ablation of the Tamm-Horsfall protein gene increases susceptibility of mice to bladder colonization by type 1-fimbriated Escherichia coli. Am J Physiol Renal Physiol 2004;286:F795-F802.
88. Thomas WE, Trintchina E, Forero M, Vogel V, Sokurenko EV. Bacterial adhesion to target cells enhanced by shear force. Cell 2002;109: 913-923.
89. Baorto DM, Gao Z, Malaviya R, Dustin ML, van der Merwe A, Lublin DM, Abraham SN. Survival of FimH-expressing enterobacteria in macrophages relies on glycolipid traffic. Nature 1997;389:636-639.
90. Shin JS, Gao Z, Abraham SN. Involvement of cellular caveolae in bacterial entry into mast cells. Science 2000;289:785-788.
91. Martinez JJ, Mulvey MA, Schilling JD, Pinkner JS, Hultgren SJ. Type 1 pilus-mediated bacterial invasion of bladder elpithelial cells. EMBO J 2000;19:2803-2812.
92. Malaviya R, Gao Z, Thankavel K, van der Merwe PA, Abraham SN. The mast cell tumor necrosis factor alpha response to FimH-expressing Escherichia coli is mediated by the glycosylphosphatidylinositol-anchored molecule CD48. Proc Natl Acad Sci U S A 1999;96: 8110-8115.
93. Martinez JJ, Hultgren SJ. Requirement of Rho-family GTPases in the invasion of Type 1-piliated uropathogenic Escherichia coli. Cell Microbiol 2002;4:19-28.
94. Duncan MJ, Li G, Shin JS, Carson JL, Abraham SN. Bacterial penetration of bladder epithelium through lipid rafts. J Biol Chem 2004;279: 11088-11095.
95. Shin JS, Abraham SN. Caveolae as portals of entry for microbes. Microbes Infect 2001;3:755-761.
96. Grimmer S, Van Deurs B, Sandvig K. Membrane ruffling and macropinocytosis in A431 cells require cholesterol. J Cell Sci 2002;115: 2953-2962.
97. Kwik J, Boyle S, Fooksman D, Margolis L, Sheetz MP, Edidin M. Membrane cholesterol, lateral mobility, and the phosphatidylinositol 4,5-bisphosphate-dependent organization of cell actin. Proc Natl Acad Sci U S A 2003;100:13964-13969.
98. Anderson GG, Palermo JJ, Schilling JD, Roth R, Hauser J, Hultgren SJ. Intracellular bacterial biofilm-like pods in urinary tract infections. Science 2003;301:105-107.
99. Rosenberger CM, Gallo RL, Finlay BB. Interplay between antibacterial effectors: a macrophage antimicrobial peptide impairs intracellular Salmonella replication. Proc Natl Acad Sci U S A 2004;101: 2422-2427.
100. Schilling JD, Martin SM, Hung CS, Lorenz RG, Hultgren SJ. Toll-like receptor 4 on stromal and hematopoietic cells mediates innate resistance to uropathogenic Escherichia coli. Proc Natl Acad Sci U S A 2003;100:4203-4208.
101. Zhang D, Zhang G, Hayden MS, Greenblatt MB, Bussey C, Flavell RA, Ghosh S. A toll-like receptor that prevents infection by uropathogenic bacteria. Science 2004;303:1522-1526.
102. Hopkins WJ, Gendron-Fitzpatrick A, Balish E, Uehling DT. Time course and host responses to Escherichia coli urinary tract infection in genetically distinct mouse strains. Infect Immun 1998;66: 2798-2802.
103. Hagberg L, Hull R, Hull S, McGhee JR, Michalek SM, Svanborg Eden C. Difference in susceptibility to gram-negative urinary tract infection between C3H/HeJ and C3H/HeN mice. Infect Immun 1984;46:839-844.
104. Schilling JD, Mulvey MA, Vincent CD, Lorenz RG, Hultgren SJ. Bacterial invasion augments epithelial cytokine responses to Escherichia coli through a lipopolysaccharide-dependent mechanism. J Immunol 2001;166:1148-1155.
105. Schilling JD, Martin SM, Hunstad DA, Patel KP, Mulvey MA, Justice SS, Lorenz RG, Hultgren SJ. CD14- and Toll-like receptor-dependent activation of bladder elpithelial cells by lipopolysaccharide and type 1 piliated Escherichia coli. Infect Immun 2003;71: 1470-1480.
106. Channaillard M, Girardin SE, Viala J, Philpott DJ. Nods, Nalps and Naip. intracellular regulators of bacterial-induced inflammation. Cell Microbiol 2003;5:581-592.
107. Jost SP. Cell cycle of normal bladder urothelium in developing and adult mice. Virchows Arch B Cell Pathol Incl Mol Pathol 1989;57:27-36.
108. Fukushi Y, Orikasa S, Kagayama M. An electron microscopic study of the interaction between vesical epitherlium and E. coli. Invest Urol 1979;17:61-68.
109. Elliott TS, Reed L, Slack RC, Bishop MC. Bacteriology and ultrastructure of the bladder in patients with urinary tract infections. J Infect 1985;11:191-199.
110. McTaggart LA, Rigby RC, Elliott TS. The pathogenesis of urinary tract infections associated with Escherichia coli, Staphylococcus saprophyticus and S. epidermidis. J Med Microbiol 1990;32:135-141.
111. McTaggart LA, Elliott TS. What makes microbes stick? Lancet 1989;1:324.
112. Aronson M, Medalia O, Amichay D, Nativ O. Endotoxin-induced shedding of viable uroepithelial cells is an antimicrobial defense mechanism. Infect Immun 1988;56:1615-1617.
113. Jezernik K, Medalia O, Aronson M. A comparative study of the desquamation of urothelial cells during gestation and in adults mice following moderate stress or endotoxin treatment. Cell Biol Int 1995;19:887-893.
114. Klumpp DJ, Weiser AC, Sengupta S, Forrestal SG, Batler RA, Schaeffer AJ. Uropathogenic Escherichia coli potentiates type 1 pilus-induced apoptosis by suppressing NF-κB. Infect Immun 2001;69:6689-6695.
115. Anderson M, Bollinger D, Hagler A, Hartwell H, Rivers B, Ward K, Steck TR. Viable but nonculturable bacteria are present in mouse and human urine specimens. J Clin Microbiol 2004;42: 753-758.
116. Romih R, Veranic P, Jezernik K. Actin filaments during terminal differentiation of urothelial cells in the rat urinary bladder. Histochem Cell Biol 1999;112:375-380.
117. Springall T, Sheerin NS, Abe K, Holers VM, Wan H, Sacks SH. Epithelial secretion of C3 promotes colonization of the upper urinary tract by Escherichia coli. Nat Med 2001;7:801-806.